Stockholders’ Deficit (Details) - Schedule of Summarizes Activity for Warrants - USD ($) |
6 Months Ended | |
|---|---|---|
Dec. 31, 2023 |
Jun. 30, 2024 |
|
| Schedule of Summarizes Activity for Warrants [Abstract] | ||
| Number of Shares Underlying Outstanding Warrants, Outstanding at Ending | 4,784,193 | 4,784,193 |
| Weighted- Average Exercise Price, Outstanding at Ending | $ 6 | $ 6 |
| Weighted- Average Remaining Contractual Term (in Years), Outstanding at Ending | 2 years 6 months 14 days | 2 years 14 days |
| Aggregate Intrinsic Value, Outstanding at Ending | ||
| Number of Shares Underlying Outstanding Warrants, Warrants granted | ||
| Weighted- Average Exercise Price, Warrants granted | ||
| Weighted- Average Remaining Contractual Term (in Years), Warrants granted | ||
| Aggregate Intrinsic Value, Warrants granted | ||
| Number of Shares Underlying Outstanding Warrants, Warrants exercised | ||
| Weighted- Average Exercise Price, Warrants exercised | ||
| Weighted- Average Remaining Contractual Term (in Years), Warrants exercised | ||
| Aggregate Intrinsic Value, Warrants exercised |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price warrant exercised. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price granted. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price warrant outstanding. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Intrinsic value of outstanding award under Warrants exercised. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Definition Intrinsic value of outstanding award under warrants granted. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. No definition available.
|